Back to search
FDAFDA · Food and drugs·Recall number D-0179-2021

Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68

Published January 6, 2021 · Recall initiated: December 17, 2020

Summary

FDA records drug Class II recall D-0179-2021, published January 6, 2021 and initiated December 17, 2020. Recalling firm: Ascend Laboratories LLC; Status: Terminated; Reported quantity: 9,524 bottles; Lot: 20141680, 20141681, 20141759. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurity/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if CEPHALEXIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CEPHALEXIN
Manufacturer
Ascend Laboratories LLC
Distributor
Nationwide
Lot
20141680, 20141681, 20141759
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ascend Laboratories, llc Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68 recalled?

Yes. FDA published recall D-0179-2021 on January 6, 2021. Reported hazard: Failed Impurity/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CEPHALEXIN.